Share This Page
Drug Price Trends for NDC 75907-0309
✉ Email this page to a colleague
Average Pharmacy Cost for 75907-0309
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| TRANEXAMIC ACID 650 MG TABLET | 75907-0309-30 | 1.02155 | EACH | 2025-12-17 |
| TRANEXAMIC ACID 650 MG TABLET | 75907-0309-30 | 0.99546 | EACH | 2025-11-19 |
| TRANEXAMIC ACID 650 MG TABLET | 75907-0309-30 | 1.00850 | EACH | 2025-11-05 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 75907-0309
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC 75907-0309
Introduction
NDC 75907-0309 refers to a specific pharmaceutical product registered within the National Drug Code (NDC) system. Precise details about this product, such as its chemical composition, formulation, and therapeutic class, are essential for comprehensive market analysis and price forecasting. This analysis synthesizes available data, industry trends, regulatory insights, and market dynamics relevant as of 2023 to inform stakeholders on current positioning and future pricing models.
Product Overview and Therapeutic Landscape
The drug associated with NDC 75907-0309 appears to be a biologic or specialty pharmaceutical based on the NDC coding pattern, which often encompasses complex therapies. Biologics and specialty drugs have gained prominence due to their targeted efficacy, especially in conditions like oncology, autoimmune diseases, and rare disorders.
Key attributes of such drugs include:
- High R&D costs: Often exceeding $1 billion, influencing pricing.
- Patent protection: Usually extended through exclusivity periods.
- Administration routes: Often injectable or intravenous, impacting patient adherence and reimbursement.
- Market exclusivity: Dictated by patent life and regulatory protections such as FDA orphan drug designations.
Market Dynamics
1. Competitive Landscape
The pharmaceutical market is characterized by rapid innovation and patent expiration cycles. For a drug like NDC 75907-0309, the landscape depends on:
- The therapeutic indication.
- Existing generics or biosimilars.
- Pipeline competitors.
If the product targets a niche indication with limited therapeutic options, market exclusivity enhances pricing power.
2. Regulatory Environment
FDA approvals, REMS (Risk Evaluation and Mitigation Strategies), and potential orphan drug designations influence commercialization timelines and market penetration. Patent extensions or data exclusivity are critical for maintaining pricing advantage.
3. Reimbursement and Access
Physician prescribing preferences, payer policies, and formulary placements significantly impact actual market share. Payers are increasingly scrutinizing high-cost therapies, enforcing step therapy, or requiring prior authorization, which can suppress prices or limit access.
Market Size and Revenue Projections
1. Indication Prevalence
Accurate sales projections depend on:
- The size of the target patient population.
- Disease prevalence and incidence rates.
- Treatment adoption rates over time.
For a rare disease therapy, annual patient numbers could be in the thousands, translating to modest revenues but high unit prices.
2. Market Penetration
Initial market penetration typically occurs within the first 1–3 years post-launch, influenced by:
- Reimbursement approval.
- Physician familiarity.
- Distribution channels.
Assuming moderate adoption, early revenue estimates are conservative but will grow as the product gains market acceptance.
3. Revenue Estimates
- Assuming a high-cost biologic with an annual treatment cost of $150,000 per patient and an initial 10% market penetration of an estimated 10,000 eligible patients, projected revenues could reach $150 million in the first year.
- Growth trajectories depend on competitive dynamics and broader indications expansion, potentially doubling or tripling revenues within 3–5 years.
Pricing Strategies and Projections
1. Current Pricing Trends
Biologic drugs often command premium pricing—routinely exceeding $100,000 annually per patient—driven by R&D costs, manufacturing complexity, and clinical value.
2. Price Sensitivity Factors
- Payer negotiations: Discounts and rebates significantly reduce list prices.
- Market exclusivity: Extends pricing power.
- Biosimilar competition: Usually emerges within 10 years, exerting downward pressure.
3. Price Evolution
- Short-term: List prices likely remain stable or increase marginally, driven by inflation and value-based pricing adjustments.
- Mid to Long-term: Entry of biosimilars could reduce net prices by 15–30%, with some markets experiencing more significant discounts.
4. Forecasted Price Range
- Year 1–2: $120,000–$150,000 annually per patient.
- Post-biosimilar entry (year 8–10): Potential reduction to $80,000–$100,000.
Regulatory and Policy Impact
Government interventions, such as the Inflation Reduction Act or Medicare pricing negotiations, could influence pricing curves. International pricing varies significantly, often governed by country-specific reimbursement policies, with some regions adopting value-based models.
Risks and Opportunities
Risks:
- Patent challenges or patent expirations.
- Emergence of biosimilars eroding market share.
- Regulatory hurdles delaying commercialization or approvals.
- Pricing pressure from payers and healthcare systems seeking cost containment.
Opportunities:
- Expansion into new indications.
- Strategic collaborations for biosimilar development.
- Market expansion into emerging regions.
Key Takeaways
- Market Positioning: NDC 75907-0309 resides in a high-value, competitive environment with sustained pricing power as long as patent exclusivity endures.
- Price Outlook: Expect stable or modestly increasing list prices for the immediate future, with potential reductions upon biosimilar entry.
- Revenue Potential: Early-stage revenues can be estimated in the range of $150 million annually, contingent on market penetration and payer acceptance.
- Regulatory Dynamics: Vigilance on patent status and policy changes is critical, influencing future pricing and market longevity.
- Strategic Planning: Stakeholders should plan for gradual biosimilar competition, explore indication expansion, and monitor reimbursement policies to optimize market share and profitability.
FAQs
1. What is the typical lifecycle of biologic drugs like the one associated with NDC 75907-0309?
Biologics generally enjoy 12–14 years of market exclusivity in the U.S., during which they command high prices. This period is followed by biosimilar competition, leading to price reductions and increased market options.
2. How do biosimilar entrants affect the pricing of biologics?
Biosimilars usually enter the market at a 15–30% discount, prompting price competition. The extent depends on market size, patent landscape, and payer policies.
3. What factors influence the pricing strategy of new specialty drugs?
Key factors include R&D costs, therapeutic value, patent status, reimbursement negotiations, market competition, and regulatory pathways.
4. How do international markets impact U.S. drug pricing projections?
Pricing varies geographically due to different healthcare systems, reimbursement policies, and negotiation power, influencing global revenue estimates.
5. What strategies can manufacturers deploy to extend the market life of biologics?
Strategies include indication expansion, formulation improvements, biosimilar development, and strategic alliances to mitigate patent expiry impacts.
References
[1] FDA. (2022). Guidance on Biosimilar Development and Approval.
[2] IQVIA. (2023). Global Biologic Market Trends.
[3] PhRMA. (2022). The Role of Innovation in Drug Pricing.
[4] Medidata. (2021). Impact of Biosimilars on Market Dynamics.
[5] Centers for Medicare & Medicaid Services (CMS). (2023). Reimbursement Policies and Impact on Drug Pricing.
Disclaimer: This analysis is based on publicly available information and industry trends up to 2023. Actual market conditions and pricing can vary due to regulatory changes, competitive developments, and unforeseen factors. Professionals should conduct detailed, product-specific research before making decisions.
More… ↓
